berberine has been researched along with okadaic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, JC; Ho, TY; Hsiang, CY; Lee, CH; Wu, HC; Wu, SL | 1 |
Duan, WB; He, F; Jiang, W; Li, S; Luo, T; Shen, XY; Wang, HQ; Xu, J; Zhou, Y | 1 |
2 other study(ies) available for berberine and okadaic acid
Article | Year |
---|---|
Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells.
Topics: Alkaloids; Anti-Inflammatory Agents; Benzophenanthridines; Berberine; Cell Survival; Ceramides; Dose-Response Relationship, Drug; Epithelial Cells; Fibroblasts; Humans; Hydrogen Peroxide; I-kappa B Proteins; Inflammation; Interleukin-1beta; Isoquinolines; Lipopolysaccharides; Lung; NF-KappaB Inhibitor alpha; Okadaic Acid; Phosphorylation; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; U937 Cells | 2007 |
Jatrorrhizine Protects Against Okadaic Acid Induced Oxidative Toxicity Through Inhibiting the Mitogen-Activated Protein Kinases Pathways in HT22 Hippocampal Neurons.
Topics: Animals; Antioxidants; Apoptosis; Berberine; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hippocampus; MAP Kinase Signaling System; Mice; Mitochondria; Neurons; Neuroprotective Agents; Okadaic Acid; Oxidative Stress | 2015 |